Drug intelligence / Profile preview

2-Methyl-3-(2-Aminothiazolo)propanal

Development stage: Unknown
Modality: Small Molecules

Overview

2-Methyl-3-(2-Aminothiazolo)propanal is a synthetic small molecule compound with the molecular formula C7H10N2OS and a molecular weight of approximately 170.23 g/mol[1][2]. It contains a thiazole ring substituted at positions 2 and 3, with an aminothiazole moiety attached to a propanal group. The compound is classified as experimental and has not been approved for any therapeutic use in the US or elsewhere[2]. According to DrugBank, its mechanism of action is listed as a renin inhibitor, suggesting potential activity against the renin enzyme involved in blood pressure regulation; however, there are no clinical trials or approved indications for this molecule[2].

Other names: 2-Methyl-3-(2-Aminothiazolo)Propanal

Targets

REN (Renin)

Beyond the preview

Go deeper on 2-Methyl-3-(2-Aminothiazolo)propanal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-Methyl-3-(2-Aminothiazolo)propanal.

Explore the full profile